How Do Patients Value the Benefit of Minimally Invasive Surgery in Cancer Treatment?
Due to the increasing cost of cancer treatment, the demand for value-based healthcare is increasing. Although several value frameworks have been developed recently in the field of oncology, the nononcological benefits of minimally invasive surgery have not been addressed. This study aimed to estimat...
Gespeichert in:
Veröffentlicht in: | Value in health 2022-07, Vol.25 (7), p.1212-1217 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Due to the increasing cost of cancer treatment, the demand for value-based healthcare is increasing. Although several value frameworks have been developed recently in the field of oncology, the nononcological benefits of minimally invasive surgery have not been addressed. This study aimed to estimate how patients value nononcological benefits in minimally invasive cancer surgery.
The value that patients placed on various benefits of cancer surgery was termed throughout the study as patient value (PV). To quantize PVs for the benefits of cancer surgery, a one-tiered analytic hierarchy process model was constructed. The model includes 6 well-known surgical outcomes, including nononcological benefits. The study participants included 303 patients with cancer and family caregivers who participated in a questionnaire survey.
The PVs for “decreased operation time,” “reduced length of hospital stay,” and “improved cosmetic results” were 0.050, 0.044, and 0.045, respectively, whereas the PVs for “increased survival,” “prevention of disease recurrence,” and “avoidance of complications” were 0.366, 0.292, and 0.203, respectively. The PV placed on nononcological benefits from minimally invasive surgery was one-tenth (10.2%) of the total value.
Nononcological benefits arising from minimally invasive surgery were relatively small but nonnegligible. This value should be considered in the process of developing a value framework for cancer surgery and shared decision making.
•Although value-based healthcare has become increasingly significant, the nononcological benefits of minimally invasive surgery in oncology have not been addressed.•The patient value placed on the nononcological benefits of minimally invasive surgery (decreased operation time, reduced length of stay, and improved cosmetic results) was approximately 10% of the total value.•Values placed on nononcological benefits were relatively small but nonnegligible, signifying the need to consider these values in shared decision making. |
---|---|
ISSN: | 1098-3015 1524-4733 |
DOI: | 10.1016/j.jval.2022.01.002 |